ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
+0.51 (6.21%)
Apr 23, 2024, 1:03 PM EDT - Market open

ARS Pharmaceuticals Statistics

Total Valuation

SPRY has a market cap or net worth of $842.46 million. The enterprise value is $614.37 million.

Market Cap 842.46M
Enterprise Value 614.37M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

SPRY has 96.50 million shares outstanding. The number of shares has increased by 138.30% in one year.

Shares Outstanding 96.50M
Shares Change (YoY) +138.30%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 27.45%
Owned by Institutions (%) 65.46%
Float 37.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 28,081.97
Forward PS n/a
PB Ratio 3.65
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 20,479.10
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 96.92, with a Debt / Equity ratio of 0.00.

Current Ratio 96.92
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -22.20% and return on invested capital (ROIC) is -29.23%.

Return on Equity (ROE) -22.20%
Return on Assets (ROA) -21.50%
Return on Capital (ROIC) -29.23%
Revenue Per Employee $1,250
Profits Per Employee -$2.27M
Employee Count 24
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +30.63% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +30.63%
50-Day Moving Average 8.75
200-Day Moving Average 6.37
Relative Strength Index (RSI) 44.00
Average Volume (30 Days) 690,858

Short Selling Information

The latest short interest is 5.50 million, so 5.70% of the outstanding shares have been sold short.

Short Interest 5.50M
Short Previous Month 4.25M
Short % of Shares Out 5.70%
Short % of Float 14.78%
Short Ratio (days to cover) 5.69

Income Statement

In the last 12 months, SPRY had revenue of $30,000 and -$54.37 million in losses. Loss per share was -$0.57.

Revenue 30,000
Gross Profit 30,000
Operating Income -67.52M
Pretax Income -54.37M
Net Income -54.37M
EBITDA -54.29M
EBIT -54.37M
Loss Per Share -$0.57
Full Income Statement

Balance Sheet

The company has $228.36 million in cash and $274,000 in debt, giving a net cash position of $228.09 million or $2.36 per share.

Cash & Cash Equivalents 228.36M
Total Debt 274,000
Net Cash 228.09M
Net Cash Per Share $2.36
Equity / Book Value 230.76M
Book Value Per Share 2.39
Working Capital 229.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.27 million and capital expenditures -$175,000, giving a free cash flow of -$59.44 million.

Operating Cash Flow -59.27M
Capital Expenditures -175,000
Free Cash Flow -59.44M
FCF Per Share -$0.62
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -225,066.67% and -181,216.67%.

Gross Margin 100.00%
Operating Margin -225,066.67%
Pretax Margin -181,216.67%
Profit Margin -181,216.67%
EBITDA Margin -180,973.33%
EBIT Margin -181,216.67%
FCF Margin -198,136.67%

Dividends & Yields

SPRY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -138.30%
Shareholder Yield -138.30%
Earnings Yield -6.45%
FCF Yield -7.06%

Analyst Forecast

The average price target for SPRY is $18.50, which is 112.16% higher than the current price. The consensus rating is "Buy".

Price Target $18.50
Price Target Difference 112.16%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 537.09%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


SPRY has an Altman Z-Score of 207.81 and a Piotroski F-Score of 2.

Altman Z-Score 207.81
Piotroski F-Score 2